Biotronik SE has patented a process for repositioning a drug-coated stent on a balloon catheter. The method involves gripping the stent with a contact element and a protection device to prevent damage while moving it in the axial direction to adjust its position on the balloon. GlobalData’s report on Biotronik SE gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Biotronik SE & Co KG - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Biotronik SE, Neuromodulation implants was a key innovation area identified from patents. Biotronik SE's grant share as of February 2024 was 50%. Grant share is based on the ratio of number of grants to total number of patents.

Process for repositioning a drug-coated stent on a balloon

Source: United States Patent and Trademark Office (USPTO). Credit: Biotronik SE & Co KG

A recently granted patent (Publication Number: US11890214B2) discloses a process for repositioning a drug-coated stent pre-crimped on a balloon of a balloon catheter. The process involves gripping the stent with at least one contact element and a protection device to prevent direct contact between the stent and the contact element. The stent is then moved in the axial direction with respect to the balloon to achieve repositioning.

Furthermore, the patent details various aspects of the process, including the movement of the contact element to reach behind the stent, the use of a protection device such as a film or a protective sheath to prevent damage to the stent during repositioning, and the monitoring of distances using sensors like cameras, capacitive sensors, or inductive sensors. The process also involves multiple contact elements and films for gripping the stent and ensuring precise repositioning. Overall, the patented process aims to provide a reliable and efficient method for repositioning drug-coated stents on balloon catheters, enhancing the effectiveness and safety of medical procedures involving such devices.

To know more about GlobalData’s detailed insights on Biotronik SE, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.